ARCHIVES

Kirsten Goldberg Leaves The Cancer Letter For ASCO

This article is from The Cancer Letter archive.

Vol. 37 No. 01 | January 7, 2011

Download PDF Visit The Full Archive

Related Articles

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

January 23, 1976

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987

Review Of NCI Intramural Program Offers Over 60 Recommendations For Change

July 7, 1995

NIH Braces For HHS Rulings ON Travel To Major Meetings.

July 20, 2001